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Background: Increasing neuroimaging studies have revealed gray matter (GM)
anomalies of several brain regions by voxel-basedmorphometry (VBM) studies in patients
with amyotrophic lateral sclerosis (ALS). A voxel-wise meta-analysis was conducted to
integrate the reported studies to determine the consistent GM alterations in ALS based
on VBM methods.
Methods: Ovid Medline, Pubmed, Emabase, and BrainMap database were searched
for relevant studies.Data were extracted by two independent researchers. Voxel-wise
meta-analysis was performed using the effect-size signed differential mapping (ES-SDM)
software.
Results: Twenty-nine VBM studies comprising 638 subjects with ALS and 622 healthy
controls (HCs) met inclusion criteria.The global GM volumes of ALS patients were
significantly decreased compared with those of HCs. GM reductions in patients were
mainly located in the right precentral gyrus, the left Rolandic operculum, the left lenticular
nucleus and the right anterior cingulate/paracingulate gyri. The right precentral gyrus
and the left inferior frontal gyrus might be potential anatomical biomarkers to evaluate
the severity of the disease, and longer disease duration was associated with more GM
atrophy in the left frontal aslant tract and the right precentral gyrus in ALS patients.
Conclusion: The results support that ALS is a complex degenerative disease involving
multisystems besides the motor system.The mechanism of asymmetric atrophy of the
motor cortex and the implication of Rolandic operculum involvement in ALS need to be
further elucidated in future studies.
Keywords: amyotrophic lateral sclerosis, gray matter, voxel-based morphometry, meta-analysis, signed
differential mapping
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by
involvement of both upper motor neuron (UMN) and lower motor neuron (LMN), with a median
survival time of 2–4 years from onset of symptoms in population-based studies (Beghi et al.,
2006). The cause of this disease remains largely unknown, but there is an increasing awareness
that the neurodegeneration of ALS is not only restricted to the motor system but also involves
sensory, language, behavior, and other cognitive fields (Strong et al., 2009). As a fully-automated
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whole-brain technique, the voxel-based morphometry (VBM)
method overcomes the limitations of region of interest (ROI)
approach that requires a priori decision concerning which
structures needed to be evaluated, therefore provides a powerful
and unbiased tool to study the gray matter (GM) changes in ALS.
Unfortunately, applications of this novel method in the study of
ALS are often limited by relatively small sample sizes, resulting in
insufficient statistical power and increased risk of false-positive
results. Whereas an independent voxel-wise meta-analysis could
further integrate VBMfindings or other functional neuroimaging
studies, and offer insights that are not apparent from individual
studies and obtain consistent results across different studies.
A recently developed meta-analytic tool, namely signed
differential mapping (SDM), has been increasingly used to
summarize functional neuroimaging results (Radua and Mataix-
Cols, 2009). The latest version called effect-size SDM (ES-
SDM) combines various positive features of earlier meta-analytic
methods, such as activation likelihood estimation and multilevel
kernel density analysis, and has been effectively applied in the
investigation of multiple disorders, such as obsessive-compulsive
disorder (Radua and Mataix-Cols, 2009), major depressive
disorder (Zhao et al., 2014), Alzheimer’s disease (Wang et al.,
2015), Parkinson’s disease (Pan et al., 2012), and also in ALS
(Chen and Ma, 2010). However, the previous meta-analysis
of VBM studies in ALS which was performed in 2010 only
included 5 studies (Chen and Ma, 2010). Furthermore, after
comprehensive retrieve and careful data check, we found that no
study with negative results was included (i.e., when no significant
differences between individuals with ALS and controls were
found) and that the authors might adopt the data of ALS patients
with frontotemporal dementia (FTD) in one study (Chang et al.,
2005). In both cases, the changes of GM in ALS patients would
be overestimated. Therefore, the present work aims to update the
voxel-wise meta-analysis of VBM studies in ALS using the latest
ES-SDM software. In addition, this meta-analysis is also intended
to explore the effect of clinical quantitative variables on the GM
alternations in ALS through meta-regression.
METHODS
Inclusion of Studies
Ovid Medline, Pubmed and Embase databases were searched
for studies published up to May 2015 that reported VBM data
in patients with ALS. Search terms included “motor neuron
disease,” “MND,” “amyotrophic lateral sclerosis,” “ALS,” and
these terms were combined using the AND operator with
“voxel-based,” “voxelwise,” “voxel-wise,” “morphometry,” “voxel-
based morphometry,” “voxel based morphometry,” “VBM” and
“gray matter.” Both text word and MeSH subject headings
were used. Language was confined to English, and reviews
were excluded in the advanced search. The BrainMap database
(http://brainmap.org/sleuth/account.html), which is an online
database of functional and structural neuroimaging results in
the form of stereotactic (x, y, z) coordinates, was also searched
for experiments of VBM in ALS. The search strategy was
supplemented by inspecting the reference lists of included
articles. The studies were considered for inclusion if they (1)
reported VBM (GM density or volume) comparison between
patients with ALS and healthy controls (HCs); (2) reported
whole brain results of GM changes of ALS patients in Talairach
or Montreal Neurological Institute (MNI) space. Studies were
excluded if they were in line with the following criteria: (1)
there was no HC group; (2) used a ROI approach; (3) the
comparisons contained a subgroup of ALS-FTD; (4) did not list
coordinates for the contrasts. When the same study population
was reported in more than one article, the data were included
only once. The authors of relevant studies were also contacted by
email when necessary. Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) guidelines were followed in this analysis
(Stroup et al., 2000).
Data Extraction
For each included study, the following data were extracted:
numbers of participants, mean age, site of symptom onset, mean
disease duration, mean ALS functional rating scale (ALSFRS)
scores or revised ALSFRS (ALSFRS-R) scores and technical
parameters of image scanning and analysis. The coordinates
in each study were independently extracted by two researchers
according to the ES-SDMmethod.
Voxel-Wise Meta-Analysis of Included
Studies
Voxel-wise meta-analysis was performed using the ES-SDM
software (version 4.31, http://www.sdmproject.com/). The
methods have been described in detail elsewhere (Radua et al.,
2012, 2014). The full width at half-maximum (FWHM) was
set at 20mm, which had excellent control for false positives
according to previous studies; and the statistical threshold was
set to be a p < 0.005 without correction for false discovery rate
(FDR), which was found to be able to optimize the balance
between sensitivity and specificity (Radua et al., 2012). Globals
analysis, Mean analysis, and Jackknife sensitivity analysis were
carried out. In order to control for possible methodological
differences observed between included studies, the analysis
was repeated several times including only those studies which
are methodologically homogenous. The last analysis was a
meta-regression of voxel values across the studies by disease
severity (proportional scores, ALSFRS/40 or ALSFRS-R/48) and
disease duration of the patients’ samples.
RESULTS
Included Studies and Sample
Characteristics
A total of 589 articles were identified. After removal of duplicate
entries, 261 articles remained and then were screened by title
and abstract. As a result, 209 were excluded because they focused
on disorders other than MND, were animal experiments or
case reports, or did not involve VBM. After full-text review,
another 23 papers were excluded for different reasons. A
flow chart of publication selection is presented in Figure 1.
Finally, 29 studies met the selection criteria and had accessible
information concerning GM changes between ALS and HC (Ellis
et al., 2001; Abrahams et al., 2005; Chang et al., 2005; Grosskreutz
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FIGURE 1 | The flow chart of the literature search in the meta-analysis.
et al., 2006; Agosta et al., 2007, 2009; Mezzapesa et al., 2007;
Thivard et al., 2007; Grossman et al., 2008; Minnerop et al., 2009;
Roccatagliata et al., 2009; Canu et al., 2011; Senda et al., 2011;
Cosottini et al., 2012, 2013; Luo et al., 2012; Tedeschi et al.,
2012; Kwan et al., 2013; Bede et al., 2013a; Cerami et al., 2014;
D’Ambrosio et al., 2014; Menke et al., 2014; Stoppel et al., 2014;
Zhang et al., 2014; Raaphorst et al., 2015; Tavazzi et al., 2015).
In total, 638 patients with ALS and 622 HCs were reported, and
210 coordinates were collected. Among the included studies, 21
studies described GM reductions in the patient group (Ellis et al.,
2001; Chang et al., 2005; Grosskreutz et al., 2006; Agosta et al.,
2007; Mezzapesa et al., 2007; Thivard et al., 2007; Grossman et al.,
2008; Agosta et al., 2009; Minnerop et al., 2009; Canu et al., 2011;
Senda et al., 2011; Cosottini et al., 2012; Tedeschi et al., 2012;
Bede et al., 2013a; Cosottini et al., 2013; Meoded et al., 2013;
Cerami et al., 2014; D’Ambrosio et al., 2014; Menke et al., 2014;
Stoppel et al., 2014; Zhang et al., 2014; Devine et al., 2015; Tavazzi
et al., 2015), and 6 studies found no significant changes between
ALS patients and HCs (Abrahams et al., 2005; Sage et al., 2007;
Minnerop et al., 2009; Roccatagliata et al., 2009; Luo et al., 2012;
Raaphorst et al., 2015), only 1 study reported both increase and
decrease of GM changes (Kwan et al., 2013). The demographic,
clinical and technique details of included VBM studies were
shown in Table 1.
Global GM Volumes
Global GM volumes were obtained from only 4 studies including
89 patients with ALS and 72 HCs (Ellis et al., 2001; Mezzapesa
et al., 2007; Zhang et al., 2014; Raaphorst et al., 2015).
Heterogeneity analysis revealed no significant variance across
studies (tau2 = 0.000, Q = 1.889, P = 0.596). The global
GM volumes of patients with ALS were significantly decreased
compared with those of HCs (655ml vs. 686ml, Z = −2.792,
P = 0.005).
Regional Differences
The included studies reported GM decrease at 209 coordinates
and increase at 1 coordinate in ALS patients compared with HCs.
As shown in Table 2, Figure 2, patients with ALS had significant
GM reductions in the bilateral Rolandic operculum (larger on the
left), the right precentral gyrus, the left lenticular nucleus (mainly
the putamen) and the right anterior cingulate/paracingulate gyri
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FIGURE 2 | Brat v1.0 (http://www.brainnetome.org/brat) software was used to visualize the anatomical distribution of GM atrophy in ALS compared
with HCs. Patients with ALS had significant GM reductions in bilateral Rolandic operculum, the right precentral gyrus, the left lenticular nucleus and the right anterior
cingulate/paracingulate gyri. The color bar indicates the range of the SDM-Z values.
from the SDM map with a threshold of p < 0.005 and cluster
size ≥10 voxels. No GM increases were found.
Sensitivity Analyses
A whole-brain Jackknife sensitivity analysis was conducted to
test the replicability of the results, which consists of repeating
the Mean analysis 29 times but systematically removing one
different study each time to recalculate the stability of the
remaining studies. As shown in Table 3, the analysis indicated
GM reductions in the left Rolandic operculum, the right
precentral gyrus, the left lenticular nucleus and the right anterior
cingulate/paracingulate gyri were highly replicable because they
were preserved in all or almost the combinations. GM decreases
in the right Rolandic operculum failed to emerge in nine of the
combinations, which we conservatively did not consider as a
significant finding.
Analyses of Subgroups
When the analyses were repeated and limited to
methodologically homogenous groups of studies, GM atrophy in
the left Rolandic operculum and right precentral gyrus remained
largely or totally unchanged. While GM decreases in other
regions identified in the main results did not survive in the
subgroups analyses, additional significant cluster in the left
inferior/superior frontal gyrus and left superior temporal gyrus
emerged (Table 3).
Meta-Regression
The meta-regression analyses showed that higher symptom
severity (proportional scores, ALSFRS scores available in 5
studies and ALSFR-R scores available in 21 studies) was
associated with decreased GM in the right precentral gyrus and
the left inferior frontal gyrus (Table 4, Figure 3). A longer disease
duration correlated with more GM atrophy in the left frontal
aslant tract and the right precentral gyrus in patients with ALS
(Table 4, Figure 4).
DISCUSSION
The present study updated the meta-analysis of GM changes in
patients with ALS and yielded some new findings. Compared
with the previous SDM meta-analysis (Chen and Ma, 2010), the
main strengths of our study included: (1) the application of the
latest version of the SDM software which is more efficient and
precise than its previous ones; (2) a larger sample size since
a sufficient number of high-quality studies have only recently
become available; (3) the unbiased inclusion of published studies
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TABLE 2 | Regional differences in GM volume between patients with ALS and HCs.
Region Maximum Clusters Jackknife sensitivity
analysis
MNI coordinate (x,y,z) SDM-Z P-values No. of voxels breakdown (No. of voxels)
Left rolandic operculum,
BA 48
−50, 4, 2 −4.027 ∼0 7067 Left frontal gyrus (1301) 28 out of 29
Left precentral gyrus (1182)
Left temporalgyrus (1083)
Left postcentral gyrus (894)
Left insula (702)
Corpus callosum (488)
Left rolandic operculum (459)
Left paracentral lobule (258)
Other/Undefined (624)
Right precentral gyrus, BA 6 42, −16, 46 −3.062 0.000005186 1544 Right precentral gyrus (798) 29 out of 29
Right postcentral gyrus (453)
Other/Undefined (293)
Left anterior
cingulate/paracingulate gyri
0,46,4 −2.395 0.000304461 873 Left anterior cingulate
/paracingulate gyri (394)
28 out of 29
Right anterior cingulate
/paracingulate gyri (212)
Left superior frontal gyrus,
medial (141)
Right superior frontal gyrus,
medial (119)
Other/Undefined (7)
Right lenticular nucleus,
putamen, BA 48
28, 16, −4 −2.291 0.000449002 383 Right lenticular nucleus,
putamen (173)
27 out of 29
Right insula (64)
Right striatum (39)
Other/Undefined (107)
Right rolandic operculum,
BA 48
52, 6, 6 −1.843 0.003767371 43 Right rolandic operculum (35) 20 out of 29
Other (8)
ALS, amyotrophic lateral sclerosis; BA, Brodmann; GM, gray matter; HC, healthy control; MNI, Montreal Neurological Institute; SDM, signed differential mapping.
TABLE 3 | Subgroup analyses of included studies.
Subgroups Left rolandic operculum, BA 48 Right precentral gyrus, BA 6 New findings
Studies using SPM (n = 18) No Yes Left inferior frontal gyrus
Studies using FWHM of 6–8mm (n = 15) No Yes Left superior temporal gyrus
Studies using GM volume (n = 23) Yes Yes Left superior temporal gyrus
Studies correcting for multiple comparisons(n = 20) Yes Yes Left inferior/superior frontal gyrus
BA, Brodmann; FWHM, full-width half maximum; GM, gray matter; SPM, statistical parametric mapping.
even if their results were negative; (4) more clear definition of
the participants as we excluded the comparisons containing a
subgroup of ALS-FTD; (5) further subgroup andmeta-regression
analyses made the current meta-analysis more comprehensive.
By analyzing data sets from 29 VBM studies, the meta-
analysis demonstrated consistent GM atrophy in the left Rolandic
operculum, the right precentral gyrus, the left lenticular nucleus
and the right anterior cingulate/paracingulate gyri in individuals
with ALS compared toHCs. These findings were highly replicable
as verified by the jackknife sensitivity analysis. However, when
methodologically homogeneous studies were analyzed separately,
only part of the results survived and revealed new findings
of GM reductions in the left inferior/superior frontal gyrus
and left superior temporal gyrus. Further meta-regression
analyses indicated higher symptom severity by proportional
functional scores was associated with decreased GM in the right
precentral gyrus and the left inferior frontal gyrus. Moreover,
increased disease duration was associated with more GM
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TABLE 4 | Meta-regression analyses of disease severity and duration on GM abnormalities in patients with ALS.
Regions Peak MNI coordinate (x,y,z) SDM-Z P-values No. of Voxels
DISEASE SEVERITY
Right precentral gyrus, BA6 32, −14, 62 −3.025 0.000030994 339
Left inferior frontal gyrus, BA 44 −54, −16, 16 −2.410 0.001145720 218
DISEASE DURATION
Left frontal aslant tract −54,4,10 −3.216 ∼0 690
Right precentral gyrus, BA4 46, −12,40 −2.373 0.000165164 327
ALS, amyotrophic lateral sclerosis; BA, Brodmann; GM, gray matter; MNI, Montreal Neurological Institute; SDM, signed differential mapping.
FIGURE 3 | Meta-regression analysis revealed that higher symptom severity was associated with more GM atrophy in the right precentral gyrus (BA 6)
and the left inferior frontal gyrus (BA 44) in ALS patients.
atrophy in the left frontal aslant tract and the right precentral
gyrus.
In accord with the previous meta-analysis (Chen and Ma,
2010), we detected regional GM loss over the whole brain
in the right precentral gyrus, and the result remained totally
unchanged in the Jackknife sensitivity analyses and the subgroup
analyses, in contrast to the reproducibility being only 3 out
of 5 in the earlier study. The motor cortex has long been
a main focus of ALS studies and advanced neuroimaging
studies have demonstrated substantial changes in this area in
patients with ALS (Foerster et al., 2013): structural imaging
and proton magnetic resonance spectroscopy (1H-MRS) studies
have provided evidence of neuronal degeneration, through
measures showing reduced cortical thickness and reductions
in N-acetylaspartate/creatine (NAA/Cr) ratio or NAA levels
(Rule et al., 2004; Han and Ma, 2010; Agosta et al., 2012;
Verstraete et al., 2012); functional magnetic resonance imaging
(fMRI) studies (Turner and Kiernan, 2012) have indicated that
increase in motor network connectivity could be a manifestation
of loss of neuronal inhibitory function, which is consistent
with the decreased GABA concentration in the motor cortex
of ALS patients found in PET studies (Foerster et al., 2012).
Furthermore, meta-regression analyses showed that studies that
included patients with more severe ALS and longer duration
were significantly more likely to report decrease GM in these
regions.
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FIGURE 4 | Meta-regression analysis revealed that longer disease duration was associated with more GM atrophy in the left frontal aslant tract and
the right precentral gyrus (BA 4) in ALS patients.
It is noteworthy that the atrophy pattern presented asymmetry
in ALS with only the right precentral gyrus being selectively
impaired. In line with our findings, Cosottini et al. (2012)
found a prevalent atrophy in the nondominant right hemisphere
in their VBM study, and an interhemispheric asymmetry was
also revealed by their fMRI data that showed more active
hyperactivation of the fronto-parietal circuit during the motor
task executed with right hand than that executed with the
left hand. The researchers assumed that the residual motor
function of ALS patients correlated with an enhanced activation
of the fronto-parietal circuit mostly on the left hemisphere
in order to preserve the more sophisticated motor function
of the dominant hand (right hand in their study), therefore
the asymmetric distribution of this circuit and cortical atrophy
suggested a higher vulnerability of the non-dominant hemisphere
to neurodegenerative process. Zhang et al. (2014) proposed
another hypothesis that side of limb-onset can predict laterality
of GM loss in ALS patients, which was demonstrated in the
subgroup comparisons that the motor cortex in the contralateral
hemisphere of the initially involved limb was most affected, thus
the left predominant GM loss in the whole group was mainly
reflective of the abnormalities caused by the subpopulation of
patients with right limb-onset. However, Devine et al. (2015)
described that subjects with ALS showed disproportionate
atrophy of the dominant (left) motor cortex hand area,
irrespective of the side of first limb weakness, and that increased
complexity of left hemispheric motor networks in right-handers
resulting in greater susceptibility to neurodegeneration might
be one of the explanations. Although, the increased statistical
power of the current meta-analysis make our results more
reliable across different studies, still our data did not allow to
fully understand the pathophysiology of this phenomenon since
the heterogeneous disease progression rate in individual ALS
patients will increase or decrease the asymmetry dominated by
motor symptoms and add to the complexity of this disease, which
require further exploration.
For the first time, we found that patients with ALS had
bilateral regional GM atrophy in the Rolandic operculum (larger
on the left), and the result remained largely unchanged in
the Jackknife sensitivity analyses. The Rolandic operculum is
located on the surface of the posterior subcentral gyrus within
the Sylvian fissure and is a part of the articulated language
output network (Kertesz, 1995; Eickhoff, 2005; Eickhoff et al.,
2006). Individuals with lesions of this area might get articulatory
disorders or phonemic fluency deficiencies (Tonkonogy and
Goodglass, 1981; Behroozmand et al., 2015; Biesbroek et al.,
2015). So we speculated that atrophy in the Rolandic operculum
might be another important reason to explain the dysarthria
symptom in ALS patients besides the damage in brainstem
motor nuclei. Consistent with our findings, a MRS study
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revealed that the NAA/Cr ratio was significantly lower in the
Rolandic operculum in the patient group, suggesting neuronal
degeneration in this region (Verma et al., 2013). Alterations
in the Rolandic operculum have been noted in Parkinson’s
disease as well (New et al., 2015), with the severity of speech-
motor impairments correlating with the left Rolandic operculum
connectivity in the voice network, which lends further support to
our theory.
Of note, GM atrophy in the left Rolandic operculum only
survived part of the subgroup analyses, and an additional
significant cluster in the left inferior/superior frontal gyrus and
left superior temporal gyrus emerged. Neuroimaging studies
report the coordinates of the “voxel” where the difference
between patients and controls is maximum from each cluster
of significant differences, which means the breakdown of a
cluster all have contributed to the abnormalities (Table 3; Radua
and Mataix-Cols, 2009). Thus, though subgroup analyses with
reduced sample size may reveal altered peak coordinates, it was
still a reflection of the same functional area adjacent to each
other, consisting of left Rolandic operculum, inferior frontal
gyrus and superior temporal gyrus in this case (Figure 2). These
findings also correspond to the regional pattern of the extra-
motor changes reported previously. In small samples of ALS
patients without dementia, cerebral activation in the frontal and
temporal regions is altered when undertaking executive and
language tasks (Abrahams et al., 2004; Goldstein et al., 2011).
The left inferior frontal gyrus is critical for verbal fluency, which
is a sensitive marker of cognitive dysfunction in ALS patients
(Goldstein and Abrahams, 2013). Besides, the meta-regression
also showed that more GM atrophy in the left inferior frontal
gyrus correlated with greater severity of the disease.
Another notable finding was GM reductions detected in
anterior cingulate cortex (ACC) and the deep gray nuclei, though
they failed to emerge in the subgroup analyses. This might be
due to a smaller sample size, since there were not so many
voxels in these two regions in the main analyses. The ACC is an
important component of the limbic system, and could act as a
monitoring system in the executive function. This area has also
been implicated in our study and in a wide range of functional
neuroimaging studies in ALS. In fMRI studies employing extra-
motor paradigms, hyperactivity in the ACC was found during
stroop tasks and socioemotional stimuli tasks (Goldstein et al.,
2011; Passamonti et al., 2013), and hypoactivity in the ACC was
found during letter fluency task (Raaphorst et al., 2014). Reduced
response in the ACC is also found to be associated with hands
movement imagery, which might reflect disruption of the normal
networks associated with motor imagery (Stanton et al., 2007).
Interestingly, ALS patients with greater UMN involvement had
more robust activation of ACC and right caudate nucleus than
those with greater LMN involvement when performing hand
movements (Tessitore et al., 2006). The enhanced activation
might be interpreted as a compensation for the structural
damage in ALS patients with greater cortical dysfunction, but
this increase will be exhausted with disease progression. Another
interesting study revealed that atrophy in anterior cingulate and
paracingulate gyrus was common across ALS, ALS-FTD and
behavioral variant FTD, suggesting that ALS and FTD lie on a
pathological continuum (Lillo et al., 2012).
The components of the deep gray nuclei have important
connections to the motor network and prefrontal cortices.
Despite the ample clinical and postmortem evidence of basal
ganglia pathology in ALS (Brettschneider et al., 2013), most
neuroimaging studies focus on cortical gray and subcortical
white matter pathology, whereas only a few volumetric changes
involving the deep gray nuclei have been described in the ALS
literature. Agosta et al. (2009) described atrophy in the right
basal ganglia in ALS; moreover, rapidly progressing patients
showedmore substantial GM loss in the right putamen compared
with both HCs and non-rapidly progressing cases. Machts
et al. (2015) demonstrated a gradient of incremental basal
ganglia pathology across the ALS-ALS/FTD spectrum. They
also further reported that the putamen atrophy in ALS was
predominantly confined to the dorsal aspect of the structure.
But it should also be noted that other studies of subcortical
pathology in ALS did not demonstrate changes in the putamen
(Bede et al., 2013b; Westeneng et al., 2015), probably due to
their unsegregated patient cohorts. Our results provide further
neuroimaging evidence for basal ganglia involvement in ALS.
There are several limitations of the methodology. Firstly,
though the SDM method is able to provide an excellent control
of false positives, it is difficult to completely avoid false-negative
results. Next, this approach is based on pooling of summarized
coordinates rather than raw statistical brain maps, which may
result in less accuracy. Furthermore, methodological differences
of included VBM studies, such as preprocessing protocols,
smoothing kernels, statistical thresholds, and adoption of GM
density or volume or cortical thickness, cannot be entirely
ruled out, though we conducted the subgroup analyses. Finally,
the meta-regression results should be taken with some caution
because of the variability in the data. The included studies
also have their limitations. On one hand, though we excluded
the comparisons containing a subgroup of ALS-FTD, a high
prevalence of executive dysfunction was present in patients with
ALS without dementia screened by the frontal assessment battery
(Barulli et al., 2015), and most of the original researches did not
offer a neuropsychological assessment of the patients; therefore
we were unable to conduct subgroup analyses or meta-regression
analyses based on the neuropsychological or cognitive symptoms,
especially the presence of executive dysfunction, because of the
limited data. On another hand, patients with bulbar-onset or
limb-onset were not studied separately, which made it impossible
to evaluate association between GM atrophy and site of onset
of the disease, especially the implication of Rolandic operculum
involvement in bulbar-onset patients.
In summary, using the ES-SDM method of meta-analysis,
we identified consistent GM reductions in patients with ALS,
mainly located in the right precentral gyrus, the left Rolandic
operculum, the right lenticular nucleus and the right anterior
cingulate/paracingulate gyri; the right precentral gyrus and
the left inferior frontal gyrus might be potential anatomical
biomarkers to evaluate the severity of the disease. These changes
suggest that ALS is a complex degenerative disease involving
language output network, limbic system, and deep gray nuclei,
besides themotor system. Themechanism of asymmetric atrophy
of the motor cortex and the implication of Rolandic operculum
involvement in ALS need to be further elucidated in future
Frontiers in Aging Neuroscience | www.frontiersin.org 9 March 2016 | Volume 8 | Article 64
Shen et al. Gray Matter Changes in ALS
clinical and neuroimaging studies. Longitudinal VBM studies
with quantitative neuropsychological tests and investigations
exploring the GM atrophy and site of onset of the disease are also
worthwhile.
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